Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Market Cap	41.63B +32.6%
Revenue (ttm)	7.81B +22.6%
Net Income	1.69B +28.7%
EPS	15.06 +28.6%
Shares Out	111.98M
PE Ratio	24.68
Forward PE	23.98
Dividend	5.20 (1.40%)
Ex-Dividend Date	n/a

Volume	178,264
Open	378.00
Previous Close	376.80
Day's Range	364.60 - 378.25
52-Week Range	251.95 - 419.00
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	May 9, 2026

About NSE:ADVENZYMES

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1957
• Employees: 338
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ADVENZYMES

Financial Performance

In fiscal year 2026, NSE:ADVENZYMES's revenue was 7.81 billion, an increase of 22.56% compared to the previous year's 6.37 billion. Earnings were 1.69 billion, an increase of 28.68%.